KPIs & Operating Metrics(New)
Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cango (CANG) Cash & Equivalents (2017 - 2025)

Cango has reported Cash & Equivalents over the past 9 years, most recently at $41.2 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 55.12% year-over-year to $41.2 million; the TTM value through Dec 2025 reached $41.2 million, down 55.12%, while the annual FY2025 figure was $41.2 million, 54.39% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $41.2 million at Cango, down from $44.9 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $337.1 million in Q1 2022 and troughed at $41.2 million in Q4 2025.
  • A 5-year average of $136.6 million and a median of $104.7 million in 2022 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: tumbled 76.26% in 2022 and later surged 166.06% in 2023.
  • Year by year, Cash & Equivalents stood at $224.4 million in 2021, then tumbled by 76.26% to $53.3 million in 2022, then surged by 166.06% to $141.7 million in 2023, then tumbled by 35.17% to $91.9 million in 2024, then crashed by 55.12% to $41.2 million in 2025.
  • Business Quant data shows Cash & Equivalents for CANG at $41.2 million in Q4 2025, $44.9 million in Q3 2025, and $117.8 million in Q2 2025.